Pancreatic Cancer Research

ResearcherWannan Medical CollegeActive in the last 2 years

Xiaoming Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4559-7413; OpenAlex author ID A5100377916. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 3 papers

Papers 5

  1. ITGB6 promotes pancreatic fibrosis and aggravates the malignant process of pancreatic cancer via JAK2/STAT3 signaling pathway. Last author DOI 10.1007/s00210-024-03003-z↗
  2. Hsp90α promotes chemoresistance in pancreatic cancer by regulating Keap1-Nrf2 axis and inhibiting ferroptosis. Co-author DOI 10.3724/abbs.2024138↗
  3. MicroRNA-485-5p targets keratin17 to regulate pancreatic cancer cell proliferation and invasion via the FAK / SRC / ERK pathway. Last author DOI 10.7150/jca.90689↗
  4. Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer. First author DOI 10.1016/j.ygeno.2020.10.039↗
  5. Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic cancer cells. Co-author DOI 10.3892/ol.2020.11469↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daohai Qian · 2 shared papers, 2024 · strength 0.44
  2. Peng Chen · 2 shared papers, 2020–2024 · strength 0.41
  3. Shihang Xi · 2 shared papers, 2020–2024 · strength 0.35
  4. Yu Zhang · 1 shared paper, 2024 · strength 0.23
  5. Ao Zhang · 1 shared paper, 2024 · strength 0.21
  6. Bin Liu · 1 shared paper, 2024 · strength 0.21
  7. Hongping Xia · 1 shared paper, 2021 · strength 0.13
  8. Hongjin Chen · 1 shared paper, 2021 · strength 0.13
  9. Xiao Mo · 1 shared paper, 2021 · strength 0.13
  10. Linhua Lan · 1 shared paper, 2021 · strength 0.13
  11. Xiaosan Fang · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.